Erasca Inc (ERAS)
1.95
+0.10
(+5.41%)
USD |
NASDAQ |
May 17, 16:00
1.95
0.00 (0.00%)
After-Hours: 20:00
Erasca Total Liabilities (Quarterly): 81.61M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 81.61M |
| December 31, 2023 | 78.61M |
| September 30, 2023 | 80.43M |
| June 30, 2023 | 77.96M |
| March 31, 2023 | 81.09M |
| December 31, 2022 | 103.06M |
| September 30, 2022 | 81.11M |
| Date | Value |
|---|---|
| June 30, 2022 | 49.76M |
| March 31, 2022 | 50.81M |
| December 31, 2021 | 44.89M |
| September 30, 2021 | 38.96M |
| June 30, 2021 | 360.38M |
| March 31, 2021 | 353.89M |
| December 31, 2020 | 238.81M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
38.96M
Minimum
Sep 2021
360.38M
Maximum
Jun 2021
122.95M
Average
80.76M
Median
Total Liabilities (Quarterly) Benchmarks
| Bristol-Myers Squibb Co | 82.48B |
| Exelixis Inc | 675.74M |
| Geron Corp | 137.21M |
| Verastem Inc | 77.32M |
| Karyopharm Therapeutics Inc | 373.41M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 370.02M |
| Shareholders Equity (Quarterly) | 288.41M |